UPDATE: Goldman Sachs Downgrades Intercept Pharmaceuticals (ICPT) to Sell
Tweet Send to a Friend
(Updated - August 20, 2021 4:54 AM EDT)
Goldman Sachs analyst Salveen Richter downgraded Intercept Pharmaceuticals (NASDAQ: ICPT) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Salveen Richter downgraded Intercept Pharmaceuticals (NASDAQ: ICPT) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
